Identification and Quantification of Stable DNA Adducts Formed from Dibenzo[a,l]pyrene or Its Metabolites in Vitro and in Mouse Skin and Rat Mammary Gland

Chemical Research in Toxicology - Tập 18 Số 6 - Trang 984-990 - 2005
Rosa Todorovic1, Prabu Devanesan1, Eleanor G. Rogan2,1, Ercole L. Cavalieri1
1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, Nebraska 68198-6805
2Environmental, Agricultural & Occupational Health Sciences

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kozin I. S., 1995, Direct determination of dibenzo[a,l]pyrene in crude extracts of environmental samples by laser excited Shpol'skii spectroscopy. Anal. Chem. 67, 1623−1626

Schubert, P., Schantz, M. M., Sander, L. C., and Wise, S. A. (2003) Determination of polycyclic aromatic hydrocarbons with molecular 990 weight 300 and 302 in environmental-matrix standard reference materials by gas chromatography/mass spectrometry.Anal. Chem.75, 234−246.

Snook M. E., 1977, Beitrag. Tabakforch., 9, 101

Mumford J. L., 1987, Indoor air sampling and mutagenicity studies of emissions from unvented coal combustion. Environ. Sci. Technol. 21, 308−311

Mumford J., 1995, China, with high lung cancer mortality associated with exposure to unvented coal smoke. Carcinogenesis 16, 3031−3036.

Cavalieri E. L., 1989, J. Cancer Res. Clin. Oncol., 115, 72, 10.1007/BF00391602

Cavalieri E. L., 1991, Carcinogenesis 12

Higginbotham S., 1993, Tumor initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis 14, 875−878, 10.1093/carcin/14.5.875

LaVoie E. J., 1993, Cancer Lett., 70, 14, 10.1016/0304-3835(93)90068-K

Gill, H. S., Kole, P. L., Wiley, J. C., Li, K.M., Higginbothan, S., Rogan, E. G., and Cavaleri, E. L. (1994) Synthesis and tumor- initiating activity in mouse skin of dibenzo[a,l]pyrenesyn- andanti-fjord-region diol epoxides.Carcinogenesis15, 2455−2460.

Huggins, C. B. (1979)Experimental Leukemia and Mammary Cancer, pp 73−79, University of Chicago Press, Chicago.

Obana H., 1981, Bull. Environ. Contam. Toxicol., 27, 27

Cavalieri E. L., 1985, Environ. Health Perspect., 64, 84, 10.1289/ehp.856469

Cavalieri E., 1992, The approach to understanding aromatic hydrocarbon carcinogenesis. The central role of radical cations in metabolic activation. Pharmacol. Ther. 55, 183−189

Conney A. H., 1982, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons:  G. H. A. Clowes Memorial lecture. Cancer Res. 42, 4875−4917

Loeb L. A., 1986, Annu. Rev. Genet., 20

Charkravarti D., 1995, Proc. Natl. Acad. Sci. U.S.A. 92

Chakravarti D., 2000, Mutat. Res., 456, 32, 10.1016/S0027-5107(00)00102-0

Li K.-M., 1995, Identification and quantitation of dibenzo[a,l]pyrene-DNA adducts formed by rat liver microsomes in vitro:  Preponderance of depurinating adducts. Biochemistry 34, 8043−8049

Ralston L. S., 1994, The potent carcinogen dibenzo[a,l]pyrene is metabolically activated to fjord-region 11,12-diol 13,14-epoxides in human mammary carcinoma MCF-7 cell cultures. Cancer Res. 54, 887−890

Ralston, L. S., Seidel, A., Luch, A., Platt, K. L., and Baird, W. M. (1995) Stereoselective activation of dibenzo[a,l]pyrene to (−)-anti(11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7.Carcinogenesis16, 2899−2907.

Ralston L. S., 1994, Identification of dibenzo[a,l]pyrene-DNA adducts formed in cell in culture and in mouse skin. Polycyclic Aromat. Compd. 2, 199−206

Cavalieri E. L., 2005, DB[a,l]P-11,12-dihydrodiol or DB[a,l]P-11,12-dihydrodiol-13,14-epoxide and in rat mammary gland treated with DB[a,l]P. Chem. Res. Toxicol. 18, 976−983.

Devanesan, P., Ariese, F., Jankowiak, R., Small, G. J., Rogan, E. G., and Cavalieri, E. L. (1999) Preparation, isolation, and characterization of dibenzo[a,l]pyrene diol epoxide-deoxyribonucleoside monophosphate adducts by HPLC and fluorescence line-narrowing spectroscopy.Chem. Res. Toxicol. 12, 789−795.

Bodell W. J., 1989, 32P-postlabeling analysis of benzo[a]pyrene-DNA adducts formed in vitro and in vivo. Chem. Res. Toxicol. 2, 312−315

Todorovic R., 1997, Determination of benzo[a]pyrene-and 7,12-dimethylbenz[a]anthracene-DNA adducts formed in rat mammary glands. Chem. Res. Toxicol. 10, 941−947

Devanesan P. D., 1992, Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro. Chem. Res. Toxicol. 5, 302−309

Rogan, E. G., Devanesan, P. D., RamaKrishna, N. V. S., Higginbotham, S., Padmavathi, N. S., Chapman, K., Cavalieri, E. L., Jeong, H., Jankowiak, R., and Small, G. J. (1993) Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin.Chem. Res. Toxicol.6, 356−363.

Hughes N. C., 1990, Covalent binding of dibenzopyrenes and benzo[a]pyrene to DNA:  Evidence for synergistic and inhibitory interactions when applied in combination to mouse skin. Carcinogenesis 11, 1611−1619

Arif J. M., 1996, Microsome-mediated bioactivation of dibenzo[a,l]pyrene and identification of DNA adducts by 32P-postlabeling. Carcinogenesis 11, 1611−1619

Arif J. M., 1999, DNA adduct formation and persistence in rat tissues following exposure to the mammary carcinogen dibenzo[a,l]pyrene. Carcinogenesis 20, 1147−1150